Wilson Sonsini Goodrich & Rosati is advising Arcellx on the transaction. Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD) announced that they have...
You must be a Standard 1 Year member to access this content.
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised EVERY on the deal while Pillsbury Winthrop Shaw Pittman represented McWin. The EVERY Company, the leading precision fermentation platform accelerating a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the deal. Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...
You must be a Standard 1 Year member to access this content.
